Home/Filings/4/0001140361-21-030364
4//SEC Filing

Benton Susan 4

Accession 0001140361-21-030364

CIK 0001228627other

Filed

Sep 2, 8:00 PM ET

Accepted

Sep 3, 4:02 PM ET

Size

4.8 KB

Accession

0001140361-21-030364

Insider Transaction Report

Form 4
Period: 2021-09-02
Benton Susan
Director
Transactions
  • Purchase

    Common Stock

    2021-09-02$4.57/sh+20,000$91,40023,976 total
Footnotes (1)
  • [F1]The price represents the weighted average price of the multiple transactions reported on this line. The shares were purchased at prices ranging from $4.52 to $4.61. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.

Issuer

Ocuphire Pharma, Inc.

CIK 0001228627

Entity typeother

Related Parties

1
  • filerCIK 0001373649

Filing Metadata

Form type
4
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 4:02 PM ET
Size
4.8 KB